It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
Author
Vianello, Caterina 1
; Cocetta, Veronica 2
; Catanzaro, Daniela 2 ; Dorn, Gerald W 3 ; De Milito, Angelo 4 ; Rizzolio, Flavio 5 ; Canzonieri, Vincenzo 6 ; Cecchin, Erika 7
; Roncato, Rossana 7 ; Toffoli, Giuseppe 7 ; Quagliariello, Vincenzo 8 ; Di Mauro, Annabella 9 ; Losito, Simona 9 ; Maurea, Nicola 8 ; Scaffa, Cono 10 ; Sales, Gabriele 11 ; Scorrano, Luca 12 ; Giacomello, Marta 13
; Montopoli, Monica 14
1 University of Padova, Department of Pharmaceutical and Pharmacological Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
2 University of Padova, Department of Pharmaceutical and Pharmacological Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
3 Washington University School of Medicine, Center for Pharmacogenomics, Department of Internal Medicine, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
4 Sprint Bioscience, Huddinge, Sweden (GRID:grid.502583.9) (ISNI:0000 0004 6003 8502); Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
5 Ca’ Foscari University of Venice, Department of Molecular Sciences and Nanosystems, Venice, Italy (GRID:grid.7240.1) (ISNI:0000 0004 1763 0578); Pathology Unit, Centro di Riferimento Oncologico di Aviano (C.R.O.) IRCCS, Aviano, Italy (GRID:grid.7240.1)
6 Pathology Unit, Centro di Riferimento Oncologico di Aviano (C.R.O.) IRCCS, Aviano, Italy (GRID:grid.7240.1); University of Trieste, Department of Medical, Surgical and Health Sciences, Trieste, Italy (GRID:grid.5133.4) (ISNI:0000 0001 1941 4308)
7 Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano, Italy (GRID:grid.418321.d) (ISNI:0000 0004 1757 9741)
8 Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy (GRID:grid.508451.d) (ISNI:0000 0004 1760 8805)
9 Pathology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy (GRID:grid.508451.d) (ISNI:0000 0004 1760 8805)
10 Gynecologic Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy (GRID:grid.508451.d) (ISNI:0000 0004 1760 8805)
11 University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
12 University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Veneto Institute of Molecular Medicine, Padova, Italy (GRID:grid.428736.c)
13 University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Department of Biomedical Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
14 University of Padova, Department of Pharmaceutical and Pharmacological Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Veneto Institute of Molecular Medicine, Padova, Italy (GRID:grid.428736.c)




1 University of Padova, Department of Pharmaceutical and Pharmacological Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
2 University of Padova, Department of Pharmaceutical and Pharmacological Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
3 Washington University School of Medicine, Center for Pharmacogenomics, Department of Internal Medicine, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
4 Sprint Bioscience, Huddinge, Sweden (GRID:grid.502583.9) (ISNI:0000 0004 6003 8502); Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
5 Ca’ Foscari University of Venice, Department of Molecular Sciences and Nanosystems, Venice, Italy (GRID:grid.7240.1) (ISNI:0000 0004 1763 0578); Pathology Unit, Centro di Riferimento Oncologico di Aviano (C.R.O.) IRCCS, Aviano, Italy (GRID:grid.7240.1)
6 Pathology Unit, Centro di Riferimento Oncologico di Aviano (C.R.O.) IRCCS, Aviano, Italy (GRID:grid.7240.1); University of Trieste, Department of Medical, Surgical and Health Sciences, Trieste, Italy (GRID:grid.5133.4) (ISNI:0000 0001 1941 4308)
7 Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano, Italy (GRID:grid.418321.d) (ISNI:0000 0004 1757 9741)
8 Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy (GRID:grid.508451.d) (ISNI:0000 0004 1760 8805)
9 Pathology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy (GRID:grid.508451.d) (ISNI:0000 0004 1760 8805)
10 Gynecologic Oncology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy (GRID:grid.508451.d) (ISNI:0000 0004 1760 8805)
11 University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
12 University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Veneto Institute of Molecular Medicine, Padova, Italy (GRID:grid.428736.c)
13 University of Padova, Department of Biology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Department of Biomedical Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
14 University of Padova, Department of Pharmaceutical and Pharmacological Sciences, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Veneto Institute of Molecular Medicine, Padova, Italy (GRID:grid.428736.c)
Pages
521
Publication year
2023
Publication date
Aug 2023
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2850915155
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.